I asked aristotle.science which was better: SubQ or IM shots for testosterone. SubQ was the answer. If you’re currently using TRT which do you prefer and why?
The Core Finding: SubQ Shows Potential Advantages
A 2022 study in The Journal of Urology comparing 234 hypogonadal men treated with intramuscular testosterone cypionate versus subcutaneous testosterone enanthate (both at 100 mg weekly) found that subcutaneous injection was associated with lower post-therapy estradiol and hematocrit levels compared to intramuscular injections. The researchers concluded that subcutaneous testosterone “represents an effective testosterone delivery system with a potentially preferable safety profile over intramuscular testosterone cypionate”.
This matters clinically because:
-
Elevated hematocrit is the most common reason men must reduce TRT dose or donate blood
-
Elevated estradiol is the most common reason men are prescribed aromatase inhibitors they may not need
Head-to-Head Comparison
| Parameter | Subcutaneous | Intramuscular | Clinical Significance |
|---|---|---|---|
| Testosterone levels achieved | Equivalent | Equivalent | No difference |
| Peak testosterone | Lower peaks | Higher peaks | IM spikes may drive more side effects |
| Trough testosterone | Higher troughs | Lower troughs | SubQ more stable between injections |
| Estradiol levels | Lower post-therapy | Higher post-therapy | SubQ may reduce need for AI |
| Hematocrit elevation | Lower | Higher | SubQ may reduce polycythemia risk |
| Pain/discomfort | Less | More | SubQ uses smaller needles, shallower depth |
| Self-administration ease | Easier | Harder (some sites) | SubQ abdomen is accessible; IM glutes require twisting |
Testosterone injection methods comparison
Why the Difference in Estradiol and Hematocrit?
The mechanism appears to be pharmacokinetic. Intramuscular injection creates a rapid absorption curve with testosterone levels spiking within 24-48 hours, often reaching supraphysiological peaks above 1,500 ng/dL on standard doses. One study found serum estradiol increased 1.7-fold within 24 hours of IM injection, driven by the testosterone spike overwhelming the aromatase enzyme system.
Subcutaneous injection creates a flatter absorption curve because adipose tissue has a less dense capillary network than muscle, so testosterone absorbs more gradually. A 52-week study of 150 hypogonadal men using weekly subcutaneous testosterone enanthate found that 92.7% achieved target testosterone levels with “small peak and trough fluctuations”.